Trial Profile
Prevention of Neonatal Abstinence Syndrome
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary)
- Indications Nausea; Neonatal-disorders
- Focus Pharmacokinetics
- Acronyms Zofran-PK
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Mar 2013 New trial record